Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by ...

By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in ...

Chief medical officer, Cardiosense. Previous title: Chief medical officer emeritus, Butterfly Network. Cardiosense has appointed John Martin as chief ...

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

The update covers devices used in procedures to implant the company’s Watchman heart device.

The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for durable medical equipment ...

The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...